In 2020, the global size for Zika Virus Testing Market reached USD 179.2 million, and it is projected to exhibit a compound annual growth rate (CAGR) of 7.9% throughout the forecast period. The increasing prevalence of Zika virus infection and the active research and development efforts undertaken by pharmaceutical companies to establish effective protocols are driving factors behind the growth...
The global Cancer Pain Market was valued at USD 6.08 Billion in 2020 and is projected to grow at a compound annual growth rate (CAGR) of 4.3% during the forecast period. Factors such as the increasing prevalence of cancer worldwide, greater recognition of cancer pain as a significant clinical issue, rising use of opioids for managing cancer pain, and the identification of potential therapeutic...
The global Intravenous (IV) Catheters Market experienced significant growth in 2020 and is projected to maintain a steady increase in revenue between 2021 and 2028. The driving factors behind this growth include the rising adoption of these products in healthcare facilities for drug administration, fluid infusion, Parenteral Nutrition, and blood sampling from patients. These products...
The Anesthesia Mask Market witnessed substantial growth in 2020 and is expected to maintain a steady revenue growth rate throughout the forecast period. Factors such as the increasing number of surgical and cosmetic procedures, the adoption of anesthesia masks by medical professionals for chronic conditions like cancer and transplants, the enhancement of healthcare infrastructure, and growing...
The global Topical Corticosteroids Market was significantly large in the year 2020 and is projected to experience a substantial increase in revenue with a rapidly rising CAGR from 2021 to 2028. The driving forces behind this growth are the increasing awareness of skin diseases in both developed and developing countries, along with a rising incidence of various skin allergies worldwide.
Topical...
The global Pecoma Market is projected to exhibit a consistent revenue compound annual growth rate (CAGR) during the forecast period, primarily attributed to the increasing prevalence of the disease and a heightened awareness of it. According to estimates from the National Organization for Rare Diseases, the incidence of malignant PEComa ranges from 0.12 to 0.24 cases per million individuals....
The global Dysmenorrhea Treatment Market is anticipated to experience a consistent growth in revenue over the forecast period. This growth in revenue within the dysmenorrhea treatment market is primarily attributed to factors such as the rising incidence of dysmenorrhea, increased awareness, and growing concern regarding dysmenorrhea among women in developed nations.
Dysmenorrhea, a...
In 2021, the global Metastatic Prostate Cancer Market experienced robust growth and is anticipated to continue expanding at a higher revenue CAGR during the projected period. This growth can be attributed to the rising incidence of cancer cases. For instance, in 2020, cancer claimed the lives of around 10 million individuals worldwide, and there were approximately 1.41 million reported cases of...
The global Inflammatory Bowel Disease(IBD) Treatment Market is projected to maintain a consistent growth rate in revenue over the forecast period due to the increasing prevalence of the condition. On a global scale, there were 396 reported cases of inflammatory bowel disease per 100,000 individuals, with approximately 6 million people worldwide suffering from IBD. Additionally, several factors,...
The research encompasses a comprehensive examination of the Global Bronchopulmonary Dysplasia Market scrutinizing its market trends to anticipate future developments from 2020 to 2027. The historical data for analysis covers 2017 and 2018, with 2019 serving as the reference year. This investigation aims to provide readers with a thorough understanding of the industry's current and forthcoming...
